{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T10:00:06Z","timestamp":1784973606519,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s11033-022-07560-5","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T20:03:36Z","timestamp":1652904216000},"page":"7521-7530","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Ethacrynic acid and cinnamic acid combination exhibits selective anticancer effects on K562 chronic myeloid leukemia cells"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0468-721X","authenticated-orcid":false,"given":"M\u00fcnevver","family":"Yenig\u00fcl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5444-3929","authenticated-orcid":false,"given":"\u0130smail","family":"Ak\u00e7ok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6559-9144","authenticated-orcid":false,"given":"Emel Ba\u015fak","family":"Gencer Ak\u00e7ok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,18]]},"reference":[{"key":"7560_CR1","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1097\/01.SMJ.0000082004.40613.D7","volume":"96","author":"JM Alisky","year":"2003","unstructured":"Alisky JM, Tuttle TF (2003) Ethacrynic acid can be effective for refractory congestive heart failure and ascites. South Med J 96:1148\u20131150. doi: https:\/\/doi.org\/10.1097\/01.SMJ.0000082004.40613.D7","journal-title":"South Med J"},{"key":"7560_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41389-017-0025-3","volume":"7","author":"N Allocati","year":"2018","unstructured":"Allocati N, Masulli M, Di Ilio C, Federici L (2018) Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases. Oncogenesis 7:8. doi: https:\/\/doi.org\/10.1038\/s41389-017-0025-3","journal-title":"Oncogenesis"},{"key":"7560_CR3","doi-asserted-by":"publisher","first-page":"e8294","DOI":"10.1371\/journal.pone.0008294","volume":"4","author":"D Lu","year":"2009","unstructured":"Lu D, Liu JX, Endo T, Zhou H, Yao S, Willert K, Schmidt-Wolf IG, Kipps TJ, Carson DA (2009) Ethacrynic acid exhibits selective toxicity to chronic lymphocytic leukemia cells by inhibition of the Wnt\/beta-catenin pathway. PLoS ONE 4:e8294. doi: https:\/\/doi.org\/10.1371\/journal.pone.0008294","journal-title":"PLoS ONE"},{"key":"7560_CR4","doi-asserted-by":"publisher","first-page":"7369","DOI":"10.1038\/sj.onc.1206940","volume":"22","author":"DM Townsend","year":"2003","unstructured":"Townsend DM, Tew KD (2003) The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 22:7369\u20137375. doi: https:\/\/doi.org\/10.1038\/sj.onc.1206940","journal-title":"Oncogene"},{"key":"7560_CR5","doi-asserted-by":"publisher","first-page":"61124","DOI":"10.1039\/C4RA12040J","volume":"4","author":"Q Yang","year":"2014","unstructured":"Yang Q, Xiao H, Cai J, Xie Z, Wang Z, Jing X (2014) Nanoparticle mediated delivery of a GST inhibitor ethacrynic acid for sensitizing platinum based chemotherapy. RSC Adv 4:61124\u201361132. doi: https:\/\/doi.org\/10.1039\/C4RA12040J","journal-title":"RSC Adv"},{"key":"7560_CR6","doi-asserted-by":"publisher","first-page":"7856","DOI":"10.1158\/0008-5472.CAN-07-0151","volume":"67","author":"R Wang","year":"2007","unstructured":"Wang R, Li C, Song D, Zhao G, Zhao L, Jing Y (2007) Ethacrynic acid butyl-ester induces apoptosis in leukemia cells through a hydrogen peroxide mediated pathway independent of glutathione S-transferase P1-1 inhibition. Cancer Res 67:7856\u20137864. doi: https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-0151","journal-title":"Cancer Res"},{"key":"7560_CR7","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/j.1349-7006.2003.tb01371.x","volume":"94","author":"S Aizawa","year":"2003","unstructured":"Aizawa S, Ookawa K, Kudo T, Asano J, Hayakari M, Tsuchida S (2003) Characterization of cell death induced by ethacrynic acid in a human colon cancer cell line DLD-1 and suppression by N-acetyl-L-cysteine. Cancer Sci 94:886\u2013893. doi: https:\/\/doi.org\/10.1111\/j.1349-7006.2003.tb01371.x","journal-title":"Cancer Sci"},{"key":"7560_CR8","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1021\/jm9011565","volume":"53","author":"X Yang","year":"2010","unstructured":"Yang X, Liu G, Li H, Zhang Y, Song D, Li C, Wang R, Liu B, Liang W, Jing Y, Zhao G (2010) Novel oxadiazole analogues derived from ethacrynic acid: design, synthesis, and structure-activity relationships in inhibiting the activity of glutathione S-transferase P1-1 and cancer cell proliferation. J Med Chem 53:1015\u20131022. doi: https:\/\/doi.org\/10.1021\/jm9011565","journal-title":"J Med Chem"},{"key":"7560_CR9","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1111\/ijfs.14051","volume":"54","author":"R Cai","year":"2019","unstructured":"Cai R, Miao M, Yue T, Zhang Y, Cui L, Wang Z, Yuan Y (2019) Antibacterial activity and mechanism of cinnamic acid and chlorogenic acid against Alicyclobacillus acidoterrestris vegetative cells in apple juice. Int J Food Sci Technol 54:1697\u20131705. doi: https:\/\/doi.org\/10.1111\/ijfs.14051","journal-title":"Int J Food Sci Technol"},{"key":"7560_CR10","doi-asserted-by":"publisher","first-page":"19292","DOI":"10.3390\/molecules191219292","volume":"19","author":"JD Guzman","year":"2014","unstructured":"Guzman JD (2014) Natural cinnamic acids, synthetic derivatives and hybrids with antimicrobial activity. Molecules 19:19292\u201319349. doi: https:\/\/doi.org\/10.3390\/molecules191219292","journal-title":"Molecules"},{"key":"7560_CR11","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1080\/14786419.2017.1317776","volume":"32","author":"TC Lima","year":"2018","unstructured":"Lima TC, Ferreira AR, Silva DF, Lima EO, de Sousa DP (2018) Antifungal activity of cinnamic acid and benzoic acid esters against Candida albicans strains. Nat Prod Res 32:572\u2013575. doi: https:\/\/doi.org\/10.1080\/14786419.2017.1317776","journal-title":"Nat Prod Res"},{"key":"7560_CR12","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.2174\/092986711795471347","volume":"18","author":"P De","year":"2011","unstructured":"De P, Baltas M, Bedos-Belval F (2011) Cinnamic acid derivatives as anticancer agents-a review. Curr Med Chem 18:1672\u20131703. doi: https:\/\/doi.org\/10.2174\/092986711795471347","journal-title":"Curr Med Chem"},{"key":"7560_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1756-9966-32-31","volume":"32","author":"EL Niero","year":"2013","unstructured":"Niero EL, Machado-Santelli GM (2013) Cinnamic acid induces apoptotic cell death and cytoskeleton disruption in human melanoma cells. J Exp Clin Cancer Res 32:31. doi: https:\/\/doi.org\/10.1186\/1756-9966-32-31","journal-title":"J Exp Clin Cancer Res"},{"key":"7560_CR14","doi-asserted-by":"publisher","first-page":"38022","DOI":"10.18632\/oncotarget.16723","volume":"8","author":"R Bayat Mokhtari","year":"2017","unstructured":"Bayat Mokhtari R, Homayouni TS, Baluch N, Morgatskaya E, Kumar S, Das B, Yeger H (2017) Combination therapy in combating cancer. Oncotarget 8:38022\u201338043. doi: https:\/\/doi.org\/10.18632\/oncotarget.16723","journal-title":"Oncotarget"},{"key":"7560_CR15","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00277-011-1212-5","volume":"90","author":"EB Gencer","year":"2011","unstructured":"Gencer EB, Ural AU, Avcu F, Baran Y (2011) A novel mechanism of dasatinib-induced apoptosis in chronic myeloid leukemia; ceramide synthase and ceramide clearance genes. Ann Hematol 90:1265\u20131275. doi: https:\/\/doi.org\/10.1007\/s00277-011-1212-5","journal-title":"Ann Hematol"},{"key":"7560_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","volume":"22","author":"T-C Chou","year":"1984","unstructured":"Chou T-C, Talalay P (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22:27\u201355. doi: https:\/\/doi.org\/10.1016\/0065-2571(84)90007-4","journal-title":"Adv Enzyme Regul"},{"key":"7560_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71:209\u2013249. doi: https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"7560_CR18","doi-asserted-by":"publisher","unstructured":"Lilenbaum RC, Herndon JE 2, List MA, Desch C, Watson DM, Miller AA, Graziano SL, Perry MC, Saville W, Chahinian P, Weeks JC, Holland JC, Green MR (2005) Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730). J Clin Oncol 23:190\u2013196. doi: https:\/\/doi.org\/10.1200\/JCO.2005.07.172","DOI":"10.1200\/JCO.2005.07.172"},{"key":"7560_CR19","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.3389\/fphar.2018.01300","volume":"9","author":"L Falzone","year":"2018","unstructured":"Falzone L, Salomone S, Libra M (2018) Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium. Front Pharmacol 9:1300. doi: https:\/\/doi.org\/10.3389\/fphar.2018.01300","journal-title":"Front Pharmacol"},{"key":"7560_CR20","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/ijc.2910620319","volume":"62","author":"L Liu","year":"1995","unstructured":"Liu L, Hudgins WR, Shack S, Yin MQ, Samid D (1995) Cinnamic acid: a natural product with potential use in cancer intervention. Int J Cancer 62:345\u2013350. doi: https:\/\/doi.org\/10.1002\/ijc.2910620319","journal-title":"Int J Cancer"},{"key":"7560_CR21","doi-asserted-by":"publisher","first-page":"4469","DOI":"10.21873\/anticanres.12749","volume":"38","author":"M Hunke","year":"2018","unstructured":"Hunke M, Martinez W, Kashyap A, Bokoskie T, Pattabiraman M, Chandra S (2018) Antineoplastic Actions of Cinnamic Acids and Their Dimers in Breast Cancer Cells: A Comparative Study. Anticancer Res 38:4469\u20134474. doi: https:\/\/doi.org\/10.21873\/anticanres.12749","journal-title":"Anticancer Res"},{"key":"7560_CR22","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.2174\/1871520620666200807222248","volume":"21","author":"A Pal","year":"2021","unstructured":"Pal A, Tapadar P, Pal R (2021) Exploring the Molecular Mechanism of Cinnamic Acid-Mediated Cytotoxicity in Triple Negative MDA-MB-231 Breast Cancer Cells. Anticancer Agents Med Chem 21:1141\u20131150. doi: https:\/\/doi.org\/10.2174\/1871520620666200807222248","journal-title":"Anticancer Agents Med Chem"},{"key":"7560_CR23","doi-asserted-by":"publisher","first-page":"4159","DOI":"10.3892\/mmr.2016.5041","volume":"13","author":"B Zhu","year":"2016","unstructured":"Zhu B, Shang B, Li Y, Zhen Y (2016) Inhibition of histone deacetylases by trans-cinnamic acid and its antitumor effect against colon cancer xenografts in athymic mice. Mol Med Rep 13:4159\u20134166. doi: https:\/\/doi.org\/10.3892\/mmr.2016.5041","journal-title":"Mol Med Rep"},{"key":"7560_CR24","doi-asserted-by":"publisher","first-page":"e0186208","DOI":"10.1371\/journal.pone.0186208","volume":"12","author":"PG Anantharaju","year":"2017","unstructured":"Anantharaju PG, Reddy DB, Padukudru MA, Chitturi CMK, Vimalambike MG, Madhunapantula SV (2017) Induction of colon and cervical cancer cell death by cinnamic acid derivatives is mediated through the inhibition of Histone Deacetylases (HDAC). PLoS ONE 12:e0186208. doi: https:\/\/doi.org\/10.1371\/journal.pone.0186208","journal-title":"PLoS ONE"},{"key":"7560_CR25","doi-asserted-by":"publisher","first-page":"105511","DOI":"10.1016\/j.ejps.2020.105511","volume":"154","author":"P Koczurkiewicz-Adamczyk","year":"2020","unstructured":"Koczurkiewicz-Adamczyk P, Piska K, Gunia-Krzyzak A, Bucki A, Jamrozik M, Lorenc E, Ryszawy D, Wojcik-Pszczola K, Michalik M, Marona H, Kolaczkowski M, Pekala E (2020) Cinnamic acid derivatives as chemosensitising agents against DOX-treated lung cancer cells - Involvement of carbonyl reductase 1. Eur J Pharm Sci 154:105511. doi: https:\/\/doi.org\/10.1016\/j.ejps.2020.105511","journal-title":"Eur J Pharm Sci"},{"key":"7560_CR26","doi-asserted-by":"publisher","first-page":"113920","DOI":"10.1016\/j.bcp.2020.113920","volume":"175","author":"YJ Lee","year":"2020","unstructured":"Lee YJ, Song H, Yoon YJ, Park SJ, Kim SY, Cho Han D, Kwon BM (2020) Ethacrynic acid inhibits STAT3 activity through the modulation of SHP2 and PTP1B tyrosine phosphatases in DU145 prostate carcinoma cells. Biochem Pharmacol 175:113920. doi: https:\/\/doi.org\/10.1016\/j.bcp.2020.113920","journal-title":"Biochem Pharmacol"},{"key":"7560_CR27","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3109\/00498259309059418","volume":"23","author":"JH Ploemen","year":"1993","unstructured":"Ploemen JH, van Ommen B, Bogaards JJ, van Bladeren PJ (1993) Ethacrynic acid and its glutathione conjugate as inhibitors of glutathione S-transferases. Xenobiotica 23:913\u2013923. doi: https:\/\/doi.org\/10.3109\/00498259309059418","journal-title":"Xenobiotica"},{"key":"7560_CR28","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/j.1365-2141.2008.07503.x","volume":"144","author":"M Schmidt","year":"2009","unstructured":"Schmidt M, Sievers E, Endo T, Lu D, Carson D, Schmidt-Wolf IGH (2009) Targeting Wnt pathway in lymphoma and myeloma cells. Br J Haematol 144:796\u2013798. doi:https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07503.x","journal-title":"Br J Haematol"},{"key":"7560_CR29","doi-asserted-by":"publisher","first-page":"114339","DOI":"10.1016\/j.bcp.2020.114339","volume":"183","author":"L Yu","year":"2021","unstructured":"Yu L, Kim HJ, Park MK, Byun HJ, Kim EJ, Kim B, Nguyen MT, Kim JH, Kang GJ, Lee H, Kim SY, Rho SB, Lee CH (2021) Ethacrynic acid, a loop diuretic, suppresses epithelial-mesenchymal transition of A549 lung cancer cells via blocking of NDP-induced WNT signaling. Biochem Pharmacol 183:114339. doi: https:\/\/doi.org\/10.1016\/j.bcp.2020.114339","journal-title":"Biochem Pharmacol"},{"key":"7560_CR30","doi-asserted-by":"publisher","first-page":"58038","DOI":"10.18632\/oncotarget.10846","volume":"7","author":"B Liu","year":"2016","unstructured":"Liu B, Huang X, Hu Y, Chen T, Peng B, Gao N, Jin Z, Jia T, Zhang N, Wang Z, Jin G (2016) Ethacrynic acid improves the antitumor effects of irreversible epidermal growth factor receptor tyrosine kinase inhibitors in breast cancer. Oncotarget 7:58038\u201358050. doi: https:\/\/doi.org\/10.18632\/oncotarget.10846","journal-title":"Oncotarget"},{"key":"7560_CR31","doi-asserted-by":"publisher","first-page":"5530673","DOI":"10.1155\/2021\/5530673","volume":"2021","author":"X Zhang","year":"2021","unstructured":"Zhang X, Huang C, Cui B, Pang Y, Liang R, Luo X (2021) Ethacrynic Acid Enhances the Antitumor Effects of Afatinib in EGFR\/T790M-Mutated NSCLC by Inhibiting WNT\/Beta-Catenin Pathway Activation. Dis Markers 2021:5530673. doi: https:\/\/doi.org\/10.1155\/2021\/5530673","journal-title":"Dis Markers"},{"key":"7560_CR32","doi-asserted-by":"publisher","first-page":"6690","DOI":"10.1158\/1078-0432.CCR-12-0770","volume":"18","author":"R Wang","year":"2012","unstructured":"Wang R, Liu C, Xia L, Zhao G, Gabrilove J, Waxman S, Jing Y (2012) Ethacrynic acid and a derivative enhance apoptosis in arsenic trioxide-treated myeloid leukemia and lymphoma cells: the role of glutathione S-transferase p1-1. Clin Cancer Res 18:6690\u20136701. doi: https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-0770","journal-title":"Clin Cancer Res"},{"key":"7560_CR33","doi-asserted-by":"publisher","first-page":"524","DOI":"10.2174\/1871520616666160607010156","volume":"17","author":"H Joshi","year":"2017","unstructured":"Joshi H, Marulkar K, Gota V, Ramaa CS (2017) Hydroxy Cinnamic Acid Derivatives as Partial PPARgamma Agonists: In silico Studies, Synthesis and Biological Characterization Against Chronic Myeloid Leukemia Cell Line (K562). Anticancer Agents Med Chem 17:524\u2013541. doi: https:\/\/doi.org\/10.2174\/1871520616666160607010156","journal-title":"Anticancer Agents Med Chem"},{"key":"7560_CR34","first-page":"2651","volume":"60","author":"C Gajate","year":"2000","unstructured":"Gajate C, Barasoain I, Andreu JM, Mollinedo F (2000) Induction of apoptosis in leukemic cells by the reversible microtubule-disrupting agent 2-methoxy-5-(2\u2019,3\u2019,4\u2019-trimethoxyphenyl)-2,4,6-cycloheptatrien-1 -one: protection by Bcl-2 and Bcl-X(L) and cell cycle arrest. Cancer Res 60:2651\u20132659","journal-title":"Cancer Res"},{"key":"7560_CR35","doi-asserted-by":"publisher","first-page":"633","DOI":"10.2174\/1573406411309050002","volume":"9","author":"M Sova","year":"2013","unstructured":"Sova M, Zizak Z, Stankovic JA, Prijatelj M, Turk S, Juranic ZD, Mlinaric-Rascan I, Gobec S (2013) Cinnamic acid derivatives induce cell cycle arrest in carcinoma cell lines. Med Chem 9:633\u2013641. doi: https:\/\/doi.org\/10.2174\/1573406411309050002","journal-title":"Med Chem"},{"key":"7560_CR36","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/MJT.0b013e3181961264","volume":"16","author":"JC Somberg","year":"2009","unstructured":"Somberg JC, Molnar J (2009) The pleiotropic effects of ethacrynic acid. Am J Ther 16:102\u2013104. doi: https:\/\/doi.org\/10.1097\/MJT.0b013e3181961264","journal-title":"Am J Ther"},{"key":"7560_CR37","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1016\/j.bmcl.2016.04.062","volume":"26","author":"SR Punganuru","year":"2016","unstructured":"Punganuru SR, Mostofa AGM, Madala HR, Basak D, Srivenugopal KS (2016) Potent anti-proliferative actions of a non-diuretic glucosamine derivative of ethacrynic acid. Bioorg Med Chem Lett 26:2829\u20132833. doi: https:\/\/doi.org\/10.1016\/j.bmcl.2016.04.062","journal-title":"Bioorg Med Chem Lett"},{"key":"7560_CR38","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ejmech.2016.05.063","volume":"122","author":"S Mignani","year":"2016","unstructured":"Mignani S, El Brahmi N, El Kazzouli S, Eloy L, Courilleau D, Caron J, Bousmina MM, Caminade AM, Cresteil T, Majoral JP (2016) A novel class of ethacrynic acid derivatives as promising drug-like potent generation of anticancer agents with established mechanism of action. Eur J Med Chem 122:656\u2013673. doi: https:\/\/doi.org\/10.1016\/j.ejmech.2016.05.063","journal-title":"Eur J Med Chem"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07560-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-022-07560-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-07560-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T18:30:39Z","timestamp":1658428239000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-022-07560-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,18]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["7560"],"URL":"https:\/\/doi.org\/10.1007\/s11033-022-07560-5","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,18]]},"assertion":[{"value":"25 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}